Reaction
Impatience reporting signals
As of the last recalculation, Impatience appears in 1,851 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is VARENICLINE TARTRATE (PRR 12.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Varenicline Tartrate | 85 | 12.5 | 12.5 |
| Lisdexamfetamine Dimesylate | 27 | 9.3 | 9.3 |
| Bupropion Hydrochloride | 64 | 7.5 | 7.5 |
| Atomoxetine Hydrochloride | 15 | 7.1 | 7.1 |
| Zonisamide | 9 | 6.9 | 6.9 |
| Methylphenidate Hydrochloride | 34 | 6.6 | 6.6 |
| Lurasidone Hydrochloride | 12 | 6.5 | 6.5 |
| Peginterferon Alfa-2A | 26 | 5.5 | 5.5 |
| Cenobamate | 4 | 5.4 | 5.4 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 4 | 5.3 | 5.3 |
| Methadone Hydrochloride | 5 | 5.2 | 5.2 |
| Desvenlafaxine Succinate | 11 | 4.6 | 4.6 |
| Relugolix | 9 | 4.3 | 4.3 |
| Alpelisib | 3 | 3.9 | 3.9 |
| Diroximel Fumarate | 4 | 3.8 | 3.8 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 4 | 3.6 | 3.6 |
| Suvorexant | 4 | 3.5 | 3.5 |
| Brexpiprazole | 5 | 3.4 | 3.4 |
| Leuprolide Acetate | 23 | 3.4 | 3.4 |
| Paliperidone Palmitate | 8 | 2.8 | 2.8 |
| Valbenazine | 6 | 2.7 | 2.7 |
| Levonorgestrel | 34 | 1.9 | 1.9 |
| Pimavanserin Tartrate | 9 | 1.8 | 1.8 |